Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease

NCT02787590 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

235

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Simvastatin
DRUG: Matched Placebo (for Simvastatin)

Sponsor

University Hospital Plymouth NHS Trust

Collaborators

[object Object]